This document discusses factors that contribute to the success of clinical trials for rare diseases. It examines which rare diseases had the most clinical trials and how sampling characteristics like gender, age, and location can affect trial success. The document also looks at trends in rare disease clinical trials and which intervention types typically have the shortest time to approval.